Factors that identify survival after liver retransplantation for allograft failure caused by recurrent hepatitis C infection

Liver Transplantation

Volumn 10, Issue 12, 2004, Pages 1497-1503

  Neff, Guy W ^a,b,c   O'Brien, Christopher B ^a,b   Nery, Jose ^a,b   Shire, Norah J ^a,b   Nishida, Seigo ^a,b   delaGarza, Julia ^a,b   Montalbano, Marzia ^a,b   Safdar, Kamran ^a,b   Ruiz, Phillip ^a,b   Rideman, Eric ^a,b   Gascon, Jose A ^a,b   Tzakis, Andreas G ^a,b   Madariaga, Juan ^a,b   Rudich, Steven M ^a,b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; INTERFERON; METHYLPREDNISOLONE; RIBAVIRIN; TACROLIMUS;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DONOR; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INCIDENCE; JAUNDICE; LIVER TRANSPLANTATION; MALE; PHYSICAL ACTIVITY; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; RECURRENT INFECTION; REOPERATION; RETROSPECTIVE STUDY; REVIEW; TREATMENT INDICATION; VIRUS LOAD;

ADULT; AGED; ANTIVIRAL AGENTS; CHRONIC DISEASE; DECISION SUPPORT TECHNIQUES; FEMALE; HEPATITIS C; HUMANS; JAUNDICE; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MOTOR ACTIVITY; POSTOPERATIVE PERIOD; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECURRENCE; REOPERATION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; VIRAL LOAD;

EID: 19944390167     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20301     Document Type: Review

References (31)

1. Broelsch CE, Burdelski M, Rogiers X, Gundlach M, Knoefel WT, Langwieler T, et al. Living donor for liver transplantation. Hepatology 1994;20:49S-55S.
2. Wight C, Cohen B. Organ shortages: Maximising the donor potential. Br Med Bull 1997;53:817-828.
3. Kauffman HM, McBride MA, Delmonico FL. First report of the United Network for Organ Sharing Transplant Tumor Registry: Donors with a history of cancer. Transplantation 2000; 70:1747-1751.
4. McMaster P. Transplantation for alcoholic liver disease in an era of organ shortage. Lancet 2000;355:424-425.
5. First MR. The organ shortage and allocation issues. Transplant Proc 2001;13:806-810.
6. Sterling RK, Fisher RA. Liver transplantation. Living donor, hepatocyte, and xenotransplantation. Clin Liver Dis 2001; 5:431-460.
7. Oz MC, Kherani AR, Rowe A, Roels L, Crandall C, Tomatis L, Young JB. How to improve organ donation: Results of the ISHLT/FACT poll. J Heart Lung Transplant 2003;22:389-410.
8. Azoulay D, Linhares MM, Huguet E, Delvart V, Castaing D, Adam R, et al. Decision for retransplantation of the liver: An experience- and cost-based analysis. Ann Surg 2002;236:713-721; discussion 721.
9. Berenguer M, Prieto M, Palau A, Rayon JM, Carrasco D, Juan FS, et al. Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus-related graft cirrhosis. Liver Transpl 2003; 9:228-235.
10. Cronin DC, Conjeevaram H, Brady L, Millis JM. Liver transplantation at the University of Chicago. Clin Transpl 1999: 231-238.
11. Charlton M. Hepatitis C infection in liver transplantation. Am J Transplant 2001;1:197-203.
12. Berenguer M. Natural history of recurrent hepatitis C. Liver Transpl 2002; 8 (suppl): S4-S18.
13. Willems M, Metselaar HJ, Tilanus HW, Schalm SW, de Man RA. Liver transplantation and hepatitis C. Transpl Int 2002; 15:61-72.
14. Charlton M, Seaberg E, Wiesner R, Everhart J, Zetterman R, Lake J, et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998;28:823-830.
15. Rakela J, Vargas HE. Hepatitis C: Magnitude of the problem. Liver Transpl 2002;8(suppl):S3-S6.
16. Charlton M. Natural history of hepatitis C and outcomes following liver transplantation. Clin Liver Dis 2003;7:585-602.
17. Ghobrial RM. Retransplantation for recurrent hepatitis C. Liver Transpl 2002;8(suppl):S38-S43.
18. Rosen HR. Retransplantation for hepatitis C: Implications of different policies. Liver Transpl 2000;6(suppl 2):S41-S46.
19. Saklad M. Grading of patients for surgical procedures. Anesthesiology 1941;2:281-284.
20. McCashland T. Retransplantation for recurrent hepatitis C: Positive aspects. Liver Transpl 2003;9:67-72.
21. Wall WJ, Khakhar A. Retransplantation for recurrent hepatitis C: The argument against. Liver Transpl 2003;9:73-78.
22. Forman LM. To transplant or not to transplant recurrent hepatitis C and liver failure. Clin Liver Dis 2003;7:615-629.
23. Sheiner PA, Schluger LK, Emre S, Thung SN, Lau JY, Guy SR, et al. Retransplantation for recurrent hepatitis C. Liver Transpl Surg 1997;3:130-136.
24. Roayaie S, Schiano TD, Thung SN, Emre SH, Fishbein TM, Miller CM, Schwartz ME. Results of retransplantation for recurrent hepatitis C. Hepatology 2003;38:1428-1436.
25. Rosen HR, Martin P. Hepatitis C infection in patients undergoing liver retransplantation. Transplantation 1998;66:1612-1616.
26. Yoo HY, Maheshwari A, Thuluvath PJ. Retransplantation of liver: Primary graft nonfunction and hepatitis C virus are associated with worse outcome. Liver Transpl 2003;9:897-904.
27. Stravitz RT, Shiffman ML, Sanyal AJ, Luketic VA, Sterling RK, Heuman DM, et al. Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation. Liver Transpl 2004;10: 850-858.
28. Davis GL. New approaches and therapeutic modalities for the prevention and treatment of recurrent HCV after liver transplantation. Liver Transpl 2003;9:S114-S119.
29. Terrault NA. Prophylactic and preemptive therapies for hepatitis C virus-infected patients undergoing liver transplantation. Liver Transpl 2003;9:S95-S100.
30. Wright TL. How can we identify better those with recurrent hepatitis C who will respond to therapy? What are the optimal treatment regimen and treatment duration? Liver Transpl 2003; 9:S109-S113.
31. Charlton MR, Ruppert K, Belle SH, Bass MN, Schafer D, Wiesner RH, et al. Long-term results and modeling to predict outcomes in recipients with HCV infection: results of the NIDDK liver transplantation database. Liver Transpl 2004;10: 1120-1130.